Understand the source comparison
Comparison: IV Therapy Timing Protocols for Common Peptide Classes
Growth Hormone Secretagogues (MK 677, GHRP-2) 4–6 hours 90 minutes post-IV Avoid dextrose solutions Short half-life demands maximum absorption window. Dextrose-induced hyperglycaemia reduces GH pulse amplitude Thymic Peptides (Thymalin, thymosin) 2–4 hours Avo
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues (MK 677, GHRP-2)
- 4–6 hours
- 90 minutes post-IV
- Avoid dextrose solutions
- Short half-life demands maximum absorption window. Dextrose-induced hyperglycaemia reduces GH pulse amplitude
- Thymic Peptides (Thymalin, thymosin)
- 2–4 hours
- Avoid high-dose vitamin C
- Glycation-sensitive due to multiple lysine residues. Requires dextrose-free IV and extended spacing
- Nootropic Peptides (Cerebrolysin, Dihexa)
- 3–8 hours
- 60–90 minutes post-IV
- Normal saline preferred
- Methionine-rich peptides vulnerable to ascorbic acid oxidation. Avoid Myers' Cocktail formulations
- GLP-1 Agonists (semaglutide, tirzepatide)
- 5–7 days
- 45–60 minutes post-IV
- No restrictions
- Extended half-life tolerates shorter spacing. Steady-state levels buffer transient dilution effects
- Short-Chain Peptides (KPV, BPC-157)
- 1–3 hours
- Avoid dextrose and ascorbic acid
- Minimal circulation time requires optimal absorption conditions. Any interference significantly reduces bioavailability